Query Trace: Pharmacogenomics[original query] |
---|
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry.
Ragia Georgia et al. Pharmacogenomics 2020 Nov |
Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
Naidoo Anushka et al. Pharmacogenomics 2019 Feb |
Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.
Cargnin Sarah et al. Pharmacogenomics 2014 May (7) 963-76 |
Note:
indicates that at least one CDC-affiliated author.
-
indicates that the article addresses aspects of implementation or evaluation in clinical or public health practice.
- Health Department: identifies articles having authors affiliated with U.S. public health departments, either at the indicated state or its sub-jurisdictions (city, county); health departments in U.S. territories are labeled Other.
Disclaimer: Advanced Molecular Detection Clips content is selected solely based on its potential interest to readers. CDC and HHS assume no responsibility for the factual accuracy of the items presented from other sources. The selection, omission, or content of items does not imply endorsement or other position taken by CDC or HHS. Opinions expressed by the original authors of selected items, or persons quoted therein, are strictly their own and are not meant to represent the opinion or views of CDC or HHS. References to products, trade names, publications, news sources, and non-CDC Web sites are provided solely for informational purposes and do not imply endorsement or other position by CDC or HHS. Advanced Molecular Detection Clips is in the public domain and may be freely forwarded and reproduced without permission. The original publications or news outlets should be cited as sources. Readers should contact the cited sources for complete information.